Get started
Author

Aleksandar Topličanin

Observed names: A Toplicanin, A Topličanin, Aleksandar Toplicanin, Topličanin, Aleksandar, Topličanin, Aleksandra
ORCID: 0000-0002-7128-0674
Observed ORCID: 0000-0002-7128-0674
OpenAlex ID: A5080803978
Diagnostic Value of Non-invasive Scoring Systems in the Prediction of Esophageal Varices in Patients with Liver Cirrhosis—Single Center Experience
2022 · Tijana Glisic, Milica Stojkovic Lalosevic, et al. · Medicina · 27
PDF
Intestinal Ultrasonography as a Tool for Monitoring Disease Activity in Patients with Ulcerative Colitis
2022 · Milica Stojkovic Lalosevic, Aleksandra Sokic Milutinovic, et al. · International Journal of Clinical Practice · 16
PDF
Hematological Indices Are Useful in Predicting Complications of Liver Cirrhosis
2023 · Tijana Glisic, Dusan D. Popovic, et al. · Journal of Clinical Medicine · 10
PDF
Autoimmune Hemolytic Anemia in Inflammatory Bowel Disease—Report of a Case and Review of the Literature
2022 · Aleksandar Toplicanin, Ljubisa Toncev, et al. · Life · 10
PDF
Muscle Function Impairment in Crohn’s Disease Patients: Risk Factors and Clinical Implications—Single-Tertiary-Center Experience
2026 · Jelena Spiric Milovancevic, Aleksandar Toplicanin, et al. · Life · 2
PDF
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn’s Disease Patients: A Rare-Variant Analysis
2026 · Biljana Stankovic, Mihajlo Stasuk, et al. · Biomedicines · 2
PDF
Impact of Depression on Health-Related Quality of Life in Ulcerative Colitis Patients—Are We Doing Enough? A Single Tertiary Center Experience
2025 · Dunja Jaksic, Sasa Vuksanovic, et al. · Life · 2
PDF
MADCAM1 Gene Variants as Potential Pharmacogenomics Markers for Vedolizumab Response in Crohn’s Disease Bio-Naïve Patients
2026 · Biljana Stankovic, Vladimir Gasic, et al. · Diagnostics
P1296 Impact of depression on health- related quality of life in Crohn’s disease patients-are we doing enough? A single tertiary center experience
2026 · D Jaksic, S Vuksanovic, et al. · Journal of Crohn s and Colitis
P0580 Persistence on vedolizumab therapy in Inflammatory Bowel Disease: A single-centre cohort analysis
2026 · S Vuksanovic, J Spirić, et al. · Journal of Crohn s and Colitis
Rare variant pharmacogenomic analysis identifies pathways associated with vedolizumab response in Crohn’s disease patients
2026 · Stanković, Biljana, Topličanin, Aleksandra, et al. · IMAGINE - Repository of the Institute of molecular genetics and genetic engineering (University of Belgrade)
P0851 Managing tuberculosis infection risk in inflammatory bowel disease patients before biological therapy initiation – Single-center experience
2025 · A Toplicanin, S Vuksanovic, et al. · Journal of Crohn s and Colitis
PDF
P1255 Impact of depression on health related quality of life in Ulcerative Colitis patients-are we doing enough? A single tertiary center experience
2025 · D Jaksic, S Vuksanovic, et al. · Journal of Crohn s and Colitis
P0987 Muscle function deficits in Crohn’s Disease patients treated with Infliximab - tertiary single centre experience
2025 · J Spirić, S Vuksanovic, et al. · Journal of Crohn s and Colitis
Exploring the relationship between HLA variants and vedolizumab response in Crohn’s disease patients
2025 · Stašuk, Mihajlo, Kotur, Nikola, et al. · IMAGINE - Repository of the Institute of molecular genetics and genetic engineering (University of Belgrade)
P842 Assessment of body composition parameters in patients with inflammatory bowel disease treated with biological therapy
2024 · J Spirić, A Topličanin, et al. · Journal of Crohn s and Colitis
PDF
P527 Factors associated with choice of treatment regimen after the induction period in patients with Ulcerative Colitis treated with vedolizumab
2024 · S Vuksanovic, J Spiric, et al. · Journal of Crohn s and Colitis
PDF
Diagnostic Delay in Crohn’s Disease: Reality Today and Strategies to Overcome It
2023 · Aleksandar Topličanin, Aleksandra Sokić Milutinović · Medical Research Archives
PDF
Works count: 18
Citation count: 69
H-index: 4
I10-index: 4
Year
Topic
Type